Clicky

Prof. Dott. Celestino Sardu Pubblicazioni Scientifiche

Recidiva della sincope cardiaca nei pazienti con diabete mellito di tipo 2 rispetto ai pazienti normoglicemici: lo studio CARVAS

Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: The CARVAS study Abstract Study hypothesis.Cardiac autonomic dysfunction might lead to higher vaso vagal syncope (VVS) recurrence rate in type 2 diabetes mellitus (T2DM) patients vs. non diabetics patients.Background.VVS recurrence might be due to alterations of autonomic system…
Read More
Prof. Dott. Celestino Sardu Pubblicazioni Scientifiche

Effetti dell’inibitore del recettore dell’angiotensina/neprilisina nei pazienti non responder alla CRTd: dall’epigenetica alla clinica

Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside Abstract Objectives. We evaluated whether Angiotensin receptor/Neprilysin inhibitors (ARNI) reduce heart failure (HF) hospitalizations and deaths in cardiac resynchronization therapy with defibrillator (CRTd) non-responders patients at 12 months of follow-up, modulating microRNAs (miRs) implied in adverse cardiac remodeling.…
Read More
Prof. Dott. Celestino Sardu Pubblicazioni Scientifiche

Effetti della terapia con SGLT2i sulle proprietà elettrofisiologiche cardiache e sulle aritmie nei pazienti diabetici con defibrillatore cardiaco impiantabile

Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator Abstract Sodium-glucose-transporter-2-inhibitors (SGLT2i) reduce ventricular-tachycardia (VT) and cardiac deaths in diabetic patients with internal-cardioverter-defibrillators (ICD) and/or cardiac-resynchronization-therapy (CRT). SGLT2i might improve cardiac electrophysiological-properties, reducing inflammation and sympathetic tone. We evaluated SGLT2i effects on…
Read More
1 … 3 4 5
Chiama ora
WhatsApp